Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma
Mucinous ovarian carcinoma (MOC) is a unique form of ovarian cancer. MOC typically presents at early stage but demonstrates intrinsic chemoresistance; treatment of advanced-stage and relapsed disease is therefore challenging. We harness a large retrospective MOC cohort to identify factors associated...
Guardado en:
Autores principales: | Robert L. Hollis, Lorna J. Stillie, Samantha Hopkins, Clare Bartos, Michael Churchman, Tzyvia Rye, Fiona Nussey, Scott Fegan, Rachel Nirsimloo, Gareth J. Inman, C. Simon Herrington, Charlie Gourley |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c8786c50a23247a98138b2bae9b70e26 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic
por: Arkan Youssef, et al.
Publicado: (2021) -
High frequency of BRAF mutations in primary mucinous ovarian carcinoma of Taiwanese patients
por: Wan-Ru Chao, et al.
Publicado: (2021) -
Clinical and Pathological Characteristics of Mucinous Colorectal Adenocarcinoma: A Comparative Study
por: Sare Hosseini, et al.
Publicado: (2016) -
Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification
por: Robert L. Hollis, et al.
Publicado: (2021) -
Anti-Angiogenesis Maintenance Therapy in Newly Diagnosed and Relapsed Ovarian Cancer: A Meta-analysis of Phase III Randomized Controlled Trials
por: Yizi Wang, et al.
Publicado: (2021)